Now on stands: Your drug may be spurious

The business of spurious drugs in India

GN Bureau | April 29, 2016


#Curtain Raiser   #Dinesh Thakur   #Health   #Medicines  


Indu Gilra, a retired teacher in her seventies living in Indirapuram, Ghaziabad in the national capital region (NCR), would often pop a tablet of Combiflam at the slightest hint of body ache. Since it’s an over-the-counter medicine, she could purchase it anywhere and it had always worked. One day, however, the pain refused to subside hours after taking the pill. Worried, she doubled her dose and yet the pain wouldn’t budge.

“I kept wondering if I had contracted some serious disease,” she says. She also wondered if there was something wrong with the medicine – she had bought it from a chemist’s shop which had opened recently in her middle-class neighbourhood. Maybe she should change the shop and not the medicine, she thought. Indu’s pain was gone after buying a strip of the same medicine from another pharmacist.
“I could make out that I had been popping spurious drugs all these days, but what could I do?”

Upset at being cheated she now decided to spread the word about her experience and at least expose the pharmacist before others. Her friend and neighbour Jaya Bhat, 74, was suffering from hypothyroidism – a condition in which a small gland located deep inside the neck region becomes sluggish and does not produce enough thyroxin hormone that plays a key role in working of the human body. For years, Jaya had been popping a 50 mg pill of Thyroxin in the morning to allow her body to make up for the missing hormone. However, of late, she had been feeling very uncomfortable, suffering palpitation, feeling extreme cold even in the peak of Delhi summer and her body bloating.

Fearing that her thyroid condition might have worsened, she got her blood tested. The doctor saw the report of the clinical test and told her that the gland had become even more sluggish and now she needed to double the dose to compensate for ever lower levels of thyroxin.
One day when the neighbours met during a routine walk they exchanged notes on health. Indu let out her rant against the new chemist. “I was lucky to have met Indu that day,” recalls Jaya, a homemaker, who too realised why she was continuing to suffer even after doubling her dose of medicine. She too changed her druggist and heaved a sigh of relief.

She has since returned to the 50-mg pill regime. “Only last week I got my blood tested for thyroxin and the result was normal,” she says.
The two women not only wasted money and suffered pain and anxiety but also consumed chemicals which could have major side effects on their health. Unfortunately, Indu and Jaya live in a region – NCR Delhi – which sees a Rs 300 crore substandard drugs trade each year. According to the industry body Associated Chambers of Commerce of India (ASSOCHAM), a third of the drugs sold in this region comprising the capital and the four townships around it – Noida, Ghaziabad, Faridabad and Gurgaon, with a total population of 4.6 crore – are substandard. The report is based on a survey it carried out in 2006-07.

Read full story about the business of spurious drugs in India in May 1-15, 2016 issue

Comments

 

Other News

Why job quota in India’s ‘Silicon Valley’ will be self-defeating

Shooting oneself in the foot with a regressive step for short term political gains is how I would define the Karnataka government’s recent decision to reserve jobs in the private sector for the state’s people. As per Nasscom, the tech sector alone contributes to 25% of the state

Union Budget: New tax regime made more attractive

Several attractive benefits to provide tax relief to salaried individuals and pensioners opting for the new tax regime were announced by finance minister Nirmala Sitharaman while presenting the Union Budget 2024-25 in Parliament on Tuesday. She proposed to increase the standard deduction for

All you want to know about Union Budget, in one place

SUMMARY OF THE UNION BUDGET 2024-2025 Key points INDIA’S INFLATION CONTINUES TO BE LOW, STABLE AND MOVING TOWARDS THE 4 PER CENT TARGET PM’S PACKAGE OF 5 SCHEMES AND INITIATIVES WITH AN OUTLAY OF  ₹ 2 L

Union Budget: A quick summary

Finance minister Nirmala Sitharaman presented the Union Budget 2024-25 in Parliament on Tuesday. The highlights of the budget are as follows: Part-A Budget Estimates 2024-25:         T

India’s real GDP projected to grow 6.5–7% in 2024-25

India’s real GDP is projected to grow 6.5–7 per cent in 2024-25. The Indian economy recovered swiftly from the pandemic, with its real GDP in FY24 being 20 per cent higher than the pre-COVID, FY20 levels. This was stated in the Economic Survey 2023-24 presented in Parliament Monday by finance m

`Women welfare & empowerment budget tripled in 10 years`

As the Indian concept of welfare transforms into empowerment, India is transitioning from women’s development to women-led development, highlights the Economic Survey 2023-2024. Tabled in the Parliament on Monday by finance minister Nirmala Sitharaman, the Economic Survey 2023-2024 fo

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter